These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22531485)

  • 1. Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.
    Hashmi JA; Baliki MN; Huang L; Parks EL; Chanda ML; Schnitzer T; Apkarian AV
    Mol Pain; 2012 Apr; 8():29. PubMed ID: 22531485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain.
    Hashmi JA; Baria AT; Baliki MN; Huang L; Schnitzer TJ; Apkarian VA
    Pain; 2012 Dec; 153(12):2393-2402. PubMed ID: 22985900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of lidocaine patch on myofascial pain syndrome of the upper trapezius: a randomized, double-blind, placebo-controlled study.
    Lin YC; Kuan TS; Hsieh PC; Yen WJ; Chang WC; Chen SM
    Am J Phys Med Rehabil; 2012 Oct; 91(10):871-82. PubMed ID: 22854911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Bischoff JM; Petersen M; Uçeyler N; Sommer C; Kehlet H; Werner MU
    Anesthesiology; 2013 Dec; 119(6):1444-52. PubMed ID: 23887198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis.
    Baliki MN; Geha PY; Jabakhanji R; Harden N; Schnitzer TJ; Apkarian AV
    Mol Pain; 2008 Oct; 4():47. PubMed ID: 18950528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of transdermal over-the-counter lidocaine 3.6% menthol 1.25%, Rx lidocaine 5% and placebo for back pain and arthritis.
    Castro E; Dent D
    Pain Manag; 2017 Nov; 7(6):489-498. PubMed ID: 28805147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial.
    Kleine-Borgmann J; Schmidt K; Hellmann A; Bingel U
    Pain; 2019 Dec; 160(12):2891-2897. PubMed ID: 31479068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine 5% Patch for Treatment of Acute Pain After Robotic Cardiac Surgery and Prevention of Persistent Incisional Pain: A Randomized, Placebo-Controlled, Double-Blind Trial.
    Vrooman B; Kapural L; Sarwar S; Mascha EJ; Mihaljevic T; Gillinov M; Qavi S; Sessler DI
    Pain Med; 2015 Aug; 16(8):1610-21. PubMed ID: 26176878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive skin analgesia with lidocaine patch for management of post-thoracotomy pain: Results of a randomized, double blind, placebo controlled study.
    Fiorelli A; Pace C; Cascone R; Carlucci A; De Ruberto E; Izzo AC; Passavanti B; Chiodini P; Pota V; Aurilio C; Santini M; Sansone P
    Thorac Cancer; 2019 Apr; 10(4):631-641. PubMed ID: 30806017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-Label Placebo Injection for Chronic Back Pain With Functional Neuroimaging: A Randomized Clinical Trial.
    Ashar YK; Sun M; Knight K; Flood TF; Anderson Z; Kaptchuk TJ; Wager TD
    JAMA Netw Open; 2024 Sep; 7(9):e2432427. PubMed ID: 39259542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
    Cheville AL; Sloan JA; Northfelt DW; Jillella AP; Wong GY; Bearden Iii JD; Liu H; Schaefer PL; Marchello BT; Christensen BJ; Loprinzi CL
    Support Care Cancer; 2009 Apr; 17(4):451-60. PubMed ID: 19142669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study.
    Demant DT; Lund K; Finnerup NB; Vollert J; Maier C; Segerdahl MS; Jensen TS; Sindrup SH
    Pain; 2015 Nov; 156(11):2234-2244. PubMed ID: 26090758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy, Effectiveness and Safety of 5% Transdermal Lidocaine Patch for Chronic Low Back Pain: A Narrative Review.
    Santana JA; Klass S; Felix ER
    PM R; 2020 Dec; 12(12):1260-1267. PubMed ID: 32189475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking increases risk of pain chronification through shared corticostriatal circuitry.
    Petre B; Torbey S; Griffith JW; De Oliveira G; Herrmann K; Mansour A; Baria AT; Baliki MN; Schnitzer TJ; Apkarian AV
    Hum Brain Mapp; 2015 Feb; 36(2):683-94. PubMed ID: 25307796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
    Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
    Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the depth and duration of anesthesia from heated lidocaine/tetracaine (Synera) patches compared with placebo patches applied to healthy adult volunteers.
    Wallace MS; Kopecky EA; Ma T; Brophy F; Campbell JC
    Reg Anesth Pain Med; 2010; 35(6):507-13. PubMed ID: 20975464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.
    Lam VY; Wallace M; Schulteis G
    J Pain; 2011 Mar; 12(3):323-30. PubMed ID: 20889387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin.
    Wehrfritz A; Namer B; Ihmsen H; Mueller C; Filitz J; Koppert W; Leffler A
    Eur J Pain; 2011 Oct; 15(9):907-12. PubMed ID: 21530339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.